Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
completion around
Principal Investigator
by Michael Conte, MD
Headshot of Michael Conte
Michael Conte

Description

Summary

The Biorepository will guide the Diabetic Foot Consortium (DFC) activities for collection and storing biosamples and data from participants enrolled in other current and future DFC research studies.

Official Title

Adjunct Collection of Additional Biorepository Data From Patients Enrolled in DFC Trials

Details

Participants enrolling in a parent DFC research study will be concurrently approached about participating in the DFC Biorepository as well. If agreeable, participants will be asked to provide blood, urine, wound debridement tissue and wound dressing samples at the time of enrollment and once more if appropriate and as coincides with the primary study visit schedule. Participants will also be contacted via phone for every six months for two years thereafter to gather longitudinal data about their wound. Data and samples from the Biorepository, along with data collected during the primary study will be available to ancillary researchers.

Keywords

Diabetic Foot Ulcer, Diabetes, diabetic foot ulcer, DFU, wound, wound healing, Diabetic Foot, Foot Ulcer

Eligibility

You can join if…

Open to people ages 18 years and up

  • Provides written informed consent
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Age > 18 years
  • Previous diagnosis of Type 1 or Type 2 diabetes or pre-diabetes per American Diabetes Association (ADA) guidelines
  • Inclusion in a part of any planned or approved DFC protocol

You CAN'T join if...

  • An individual who meets exclusion criteria of the primary DFC protocol in which they are enrolled will also be excluded from participation in the biorepository program as well.

Locations

  • UCSF accepting new patients
    San Francisco California 94143 United States
  • Stanford University accepting new patients
    Palo Alto California 94305 United States

Lead Scientist at UCSF

  • Michael Conte, MD
    Professor, Surgery, School of Medicine. Authored (or co-authored) 304 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of Michigan
ID
NCT05092620
Study Type
Observational
Participants
Expecting 500 study participants
Last Updated